Bioventus (BVS) Share-based Compensation (2022 - 2026)

Bioventus' Share-based Compensation history runs 5 years deep, the most recent figure standing at $3.3 million for Q1 2026.

• Quarterly Share-based Compensation changed N/A year-over-year to $3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.9 million (up 633.01% YoY) and the FY2025 annual result came in at $12.7 million, changed N/A from the prior year.
• Share-based Compensation was $3.3 million for Q1 2026 at Bioventus, down from $12.7 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $12.7 million in Q4 2025 and bottomed at -$11.3 million in Q4 2024.
• A 5-year average of $1.4 million and a median of $2.7 million in 2024 frame the typical range for Share-based Compensation.
• Peak annual rise in Share-based Compensation reached 311.46% in 2024, while the deepest fall reached 734.25% in 2024.
• Bioventus' Share-based Compensation stood at -$10.8 million in 2022, then jumped by 116.43% to $1.8 million in 2023, then plunged by 734.25% to -$11.3 million in 2024, then soared by 212.49% to $12.7 million in 2025, then slumped by 74.23% to $3.3 million in 2026.
• Business Quant data shows BVS's Share-based Compensation at $3.3 million in Q1 2026, $12.7 million in Q4 2025, and -$6.0 million in Q3 2025.